RIV Capital Inc.m released its financial results for the fourth quarter and fiscal year ended March 31, 2021, which proved to be a very transitional period for the company. Riv reported operating income (before equity method investees and fair value changes) of $0.7 million for the quarter. The company said that the operating income primarily consisted of royalty and interest income from its royalty and debenture agreements with Agripharm Corp., Greenhouse Juice Company, Radicle Medical Marijuana Inc., and Tweed Tree Lot, as well as lease income generated from the company’s lease agreement with Tweed Tree Lot. Riv also delivered a total comprehensive income of $64.8 million for the quarter, versus a total comprehensive loss of $36.8 million for the same period last year. The net change in the fair value of financial assets that are reported at fair value through other comprehensive income was an increase of $86.3 million, primarily driven by the positive change of $109.4 million in the fair value of the company’s exchangeable shares in TerrAscend.
Mark Johnston, Green Market Report, 06/03/2021 08:49:00
Open article: https://www.greenmarketreport.com/riv-capital-stays-on-path-to-crossover-to-u-s-cannabis/?utm_source=rss&utm_medium=rss&utm_campaign=riv-capital-stays-on-path-to-crossover-to-u-s-cannabis